OC-0541: Automated treatment planning for prospective QA in the TRENDY randomized trial on liver-SBRT for HCC
Steven Habraken, Alejandra Méndèz Romero(Erasmus MC), X. Mirabel(American Society of Clinical Oncology), Enrica Seravalli, Tom Depuydt, Reinhilde Weytjens, Jeroen Buijsen(Maastricht University Medical Centre), A.W. Sharfo, Pètra M. Braam(Radboud University Nijmegen), Oliver Riesterer, Lieselotte Depuydt, Karin Haustermans(Radboud University Nijmegen), G.H. Westerveld, T. Lacornerie, Michel Öllers(Maastricht University Medical Centre), M. Wendling(Radboud University Nijmegen), Ben Heijmen(Erasmus MC Cancer Institute), Stefan Lang(Friedrich-Alexander-Universität Erlangen-Nürnberg), N. Van Wieringen, O. Reerink, W. Verbakel, Cornelis J.A. Haasbeek(University of Amsterdam)
Cited by 0
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
|Radiotherapy and Oncology|2005|1.6k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k